Skip to main
SIBN
SIBN logo

SI-BONE Inc (SIBN) Stock Forecast & Price Target

SI-BONE Inc (SIBN) Analyst Ratings

Based on 12 analyst ratings
Strong Buy
Strong Buy 58%
Buy 42%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SI-BONE Inc. has demonstrated significant growth in its operations, with total revenue for 4Q24 reaching $49.0 million, marking a 26% year-over-year increase that aligns with prior projections. The company has expanded its sales force and active surgeon count, which rose approximately 23% year-over-year to around 1,400, indicating strong demand and improved engagement in their minimally invasive surgical products. Furthermore, SI-BONE's gross margin improved to 79.1%, exceeding consensus expectations, and productivity metrics per physician also showed promising upward trends, suggesting a solid foundation for future growth.

Bears say

The analysis indicates a negative outlook for SI-BONE, driven by an assumption of weaker-than-expected revenue growth domestically and persistent challenges in international markets, with projections estimating significant underperformance in order to achieve a valuation around $13 per share. Furthermore, the company has a history of substantial financial losses, anticipated to continue in the near term, raising concerns about potential cash burn that may necessitate additional capital raises. Additional risks, including competitive pressures, patent expirations, sales execution issues, adverse market conditions, and reimbursement challenges, further contribute to the uncertainty surrounding the company's financial stability and growth trajectory.

SI-BONE Inc (SIBN) has been analyzed by 12 analysts, with a consensus rating of Strong Buy. 58% of analysts recommend a Strong Buy, 42% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SI-BONE Inc (SIBN) Forecast

Analysts have given SI-BONE Inc (SIBN) a Strong Buy based on their latest research and market trends.

According to 12 analysts, SI-BONE Inc (SIBN) has a Strong Buy consensus rating as of Jul 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $27.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $27.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SI-BONE Inc (SIBN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.